Long-term results from cyclocryotherapy applied to the 3o'clock and 9o'clock positions in blind refractory glaucoma patientsopen access
- Authors
- Kim, B.S.; Kim, Y.J.; Seo, S.W.; Yoo, J.M.; Kim, S.J.
- Issue Date
- 2015
- Keywords
- Cryotherapy; Refractory glaucoma
- Citation
- Korean journal of ophthalmology : KJO, v.29, no.1, pp 47 - 52
- Pages
- 6
- Indexed
- SCOPUS
KCI
- Journal Title
- Korean journal of ophthalmology : KJO
- Volume
- 29
- Number
- 1
- Start Page
- 47
- End Page
- 52
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/18429
- DOI
- 10.3341/kjo.2015.29.1.47
- ISSN
- 1011-8942
2092-9382
- Abstract
- PURPOSE: To report the long-term follow-up results after cyclocryotherapy, applied to the 3-o'clock and 9-o'clock positions in blind refractory glaucoma patients.METHODS: We retrospectively reviewed the charts of 19 blind patients, and a total of 20 eyes with refractory glaucoma who were treated with cyclocryotherapy. Cyclocryotherapy treatments were performed using a retinal cryoprobe. The temperature of each cyclocryotherapy spot was -80°C and each spot was maintained in place for 60 seconds. Six cyclocryotherapy spots were placed in each quadrant, including the 3-o'clock and 9-o'clock positions.RESULTS: The mean baseline pretreatment intraocular pressure (IOP) in all eyes was 50.9 ± 12.5 mmHg, which significantly decreased to a mean IOP at last follow-up of 14.1 ± 7.1 mmHg (p < 0.001). The mean number of antiglaucoma medications that patients were still taking at last follow-up was 0.3 ± 0.6. Devastating post-procedure phthisis occurred in only one eye.CONCLUSIONS: Cyclocryotherapy, performed at each quadrant and at the 3-o'clock and 9-o'clock position, is an effective way to lower IOP and, thus, is a reasonable treatment option for refractory glaucoma patients who experience with ocular pain and headaches.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.